Propanc Biopharma Inc PPCB
$1.08 $0.02 (1.82%) 1D
Last Updated: Aug 21, 12:00 AM·NASDAQ
Pricing for US stocks is delayed by 24 hours
PPCB Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Propanc Biopharma Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Propanc Biopharma Inc. Stock Analysis PPCB
United States Health Care Nano Cap Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm is focused on the development of novel cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate, PRP, is a variation upon its formulation and involves pro-enzymes, the inactive precursors of enzymes. PRP is a long-term therapy based on pancreatic proenzyme formulation to prevent tumor recurrence and metastasis. PRP is a patented, formulation consisting of two proenzymes mixed in a synergetic ratio. PRP is in the preclinical phase of development. Its drug pipeline also includes POP1.
Propanc Biopharma Inc (PPCB) Chart
Financial Metrics & Statements of Propanc Biopharma Inc (PPCB)
FAQ's for Propanc Biopharma Inc (PPCB)
- As of August 2026, Propanc Biopharma Inc PPCB is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Propanc Biopharma Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Propanc Biopharma Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Propanc Biopharma Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Propanc Biopharma Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Propanc Biopharma Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Propanc Biopharma Inc (PPCB)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
